Pay in 4 interest-free payments of $7.13 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
Dual Receptor Agonism: Tirzepatide acts as a dual agonist of the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors
Per-Component Trial Evidence Retatrutide The Jastreboff et al
Clinical research demonstrates that PT-141 enhances both subjective and physiological measures of sexual response
The most popular and effective FDA-approved weight loss shots are: Ozempic (semaglutide) Weekly injection Wegovy (semaglutide, higher dose) Weekly injection Mounjaro (tirzepatide) Weekly dual-agonist injection Zepbound (tirzepatide) Specifically FDA-approved for weight management Other prescription and off-label injectables include Saxenda (liraglutide) and B12/Lipo shots, but the GLP-1/GIP medications above deliver the most dramatic, research-backed results
US$ 24.52
US$ 20.34
US$ 29.11
US$ 21.71
US$ 23.80
US$ 20.63
